Marker Therapeutics Inc (MRKR)

[Phantom Lord]

Obviously we can't know until we see the data but I think we will definitely see something in terms of efficacy. We already know the therapy is safe. That shouldn't change in the pancreatic cancer trial. The massive increase in enrollment in the short time frame and the rush to get the data presented at a medical conference leads me to believe we are going to get some decent data related to efficacy coupled with the already amazing safety profile.